On July 26, 2023, FDA released a guidance document on a program at FDA’s Center for Drug Evaluation and Research (CDER) to publicize a listing of accepted voluntary consensus standards…
A constructive meeting between Biopharma and Site Head Stada Inna Udovenko took place on July 20, 2023. The goal was to discuss cooperation on testing Stada products, which will improve…